Table 1.
Malignant lesions | n | Benign lesions | n |
---|---|---|---|
Invasive ductal carcinoma NOS | 53 (81.6 %) | Fibroadenoma | 24 (40.7 %) |
Invasive lobular carcinoma | 6 (9.2 %) | Fibroadenomatous hyperplasia | 8 (13.6 %) |
Ductal carcinoma in situ | 4 (6.2 %) | Papilloma | 5 (8.5 %) |
Mucinous carcinoma | 1 (1.5 %) | Fibrosis | 4 (6.7 %) |
Neuroendocrine carcinoma | 1 (1.5 %) | Others | 18 (30.5 %) |
Percentages are given in parentheses. NOS not otherwise specified